ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.

February 12, 1993

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

NCI Contract Awards.

February 18, 2000

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

Gleevec Decreases Recurrence Of Gastrointestinal Tumor

April 27, 2007